CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2742297&ei=oIaaUpjiMKTisQeQfQ&usg=AFQjCNFBrlql-9bdWQ6BllUtb98DGpYHeQ
Celgene Corp Raises FY 2013 EPS Guidance; Reaffirms FY 2013 Revenue Guidance
Thursday, 25 Apr 2013 07:29am EDT
Celgene Corp announced that for fiscal 2013, it raises adjusted diluted EPS guidance to a range of $5.55 to $5.65 from a range of $5.50 to $5.60 and total net product sales guidance is affirmed to $6.0 billion. GAAP diluted EPS expected to be in the range of $4.32 to $4.47 which includes upfront payment expense for alliances and collaborations.Â 
